Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endocrine Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00652288
What this trial is testing

Evaluation of Pharmacokinetics and Pharmacodynamic Properties of Rapid-Acting Insulin Analogs

Who this might be right for
Diabetes Mellitus, Type I
Yale University 36
Testing effectiveness (Phase 2)WithdrawnNCT00850161
What this trial is testing

Intranasal Insulin and Its Effect on Postprandial Metabolism in Comparison to Subcutaneous Insulin

Who this might be right for
Type 1 Diabetes Mellitus
CPEX Pharmaceuticals Inc.
Large-scale testing (Phase 3)Study completedNCT00467870
What this trial is testing

Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men

Who this might be right for
HypogonadismPrimary HypogonadismSecondary Hypogonadism
Endo USA Inc., a Keenova Therapeutics Company 531
Testing effectiveness (Phase 2)Study completedNCT00003670
What this trial is testing

Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Eli Lilly and Company
Not applicableEnded earlyNCT02149173
What this trial is testing

F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy

Who this might be right for
Estrogen Receptor PositiveRecurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7
University of Washington 29
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07393373
What this trial is testing

Open-Label, Long-Term, Extension Study of Infigratinib in Children With Hypochondroplasia

Who this might be right for
Hypochondroplasia
QED Therapeutics, a BridgeBio company 135
Post-approval studies (Phase 4)Study completedNCT02061969
What this trial is testing

ADA Linagliptin in Long Term Care

Who this might be right for
Diabetes
Emory University 140
Not applicableTemporarily pausedNCT02841969
What this trial is testing

Management of the Diabetic Foot Using Electrolysed Water

Who this might be right for
Diabetic Foot
NHS Lanarkshire 200
Not applicableEnded earlyNCT04909983
What this trial is testing

An Explorative Study of Treatment of Contact Dermatitis Due to DiabetesDevices

Who this might be right for
Contact Dermatitis IrritantType 1 Diabetes
Copenhagen University Hospital at Herlev 17
Not applicableStudy completedNCT00887094
What this trial is testing

Aerobic Training, Aerobic-resistance Training and Glucose Profile (CGMS) in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2TreatmentExercise
Hospital de Clinicas de Porto Alegre 14
Not applicableStudy completedNCT03993366
What this trial is testing

Pramlintide and Fiasp Closed-Loop With a Simple Meal Announcement

Who this might be right for
Type 1 Diabetes Mellitus
McGill University 8
Early research (Phase 1)Study completedNCT00972322
What this trial is testing

Pharmacokinetics and Pharmacodynamics of MK-8245 in Participants With Type 2 Diabetes (MK-8245-012)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 56
Testing effectiveness (Phase 2)Study completedNCT01583322
What this trial is testing

Vargatef in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
ARCAGY/ GINECO GROUP 188
Testing effectiveness (Phase 2)Study completedNCT01754337
What this trial is testing

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults and Adolescents With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Institut de Recherches Cliniques de Montreal 30
Testing effectiveness (Phase 2)Study completedNCT04838145
What this trial is testing

The Diabetes Virus Detection and Intervention Trial

Who this might be right for
Type1 Diabetes MellitusEnterovirus
Oslo University Hospital 96
Not applicableLooking for participantsNCT06452862
What this trial is testing

Multimodal Magnetic Resonance Imaging in Evaluation of Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Shengjing Hospital 150
Not applicableStudy completedNCT04763746
What this trial is testing

The Measurement of VItal SIgns by Lifelight® Software in comparisON to the Standard of Care - Multi-site Development

Who this might be right for
Respiratory DisorderDiabetesCardiovascular Diseases+3 more
Xim Limited 1,869
Not applicableUnknownNCT03377946
What this trial is testing

Effect of Probiotics on Pre-diabetes and Diabetes in China

Who this might be right for
Type 2 Diabetes Mellitus
Chinese PLA General Hospital 220
Not applicableStudy completedNCT02077946
What this trial is testing

A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers in Sweden

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 1,059
Testing effectiveness (Phase 2)Ended earlyNCT05116046
What this trial is testing

Continuation Study of Long-term Safety, Tolerability, Pharmacokinetics and Efficacy of Recifercept in Achondroplasia

Who this might be right for
Achondroplasia
Pfizer 35
Next Page